SEC Form 4 · accession 0001437749-15-005869
RESPONSE BIOMEDICAL CORP · RBM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Barbara Kinnaird-Steen
Officer — Chief Operating Officer
Period of report
Mar 19, 2015
Accepted (ET)
Mar 23, 2015 · 8:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000806888
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1,F2 | $0.92 | Mar 19, 2015 | A | 22,000 | A | — | Mar 19, 2025 | Common Stock | 22,000 | 22,000 | D |
Explanation of responses
- F1Exercise prices shown are denominated in Canadian dollars.
- F225% of the options shall vest and become exercisable on March 20, 2016, and 1/48th of the options shall vest over the next 36 months commencing on the first day of each calendar month beginning April 1, 2016, subject to the reporting person's continued employment with the Company through each vesting date.